MD434Z5 - Method of predicting the course of endogenous uveitis - Google Patents

Method of predicting the course of endogenous uveitis

Info

Publication number
MD434Z5
MD434Z5 MDS20100208A MDS20100208A MD434Z5 MD 434 Z5 MD434 Z5 MD 434Z5 MD S20100208 A MDS20100208 A MD S20100208A MD S20100208 A MDS20100208 A MD S20100208A MD 434 Z5 MD434 Z5 MD 434Z5
Authority
MD
Moldova
Prior art keywords
course
predicting
endogenous uveitis
uveitis
endogenous
Prior art date
Application number
MDS20100208A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Валериу КУШНИР
Лилия ДУМБРЭВЯНУ
Еуджения САМОТЫЯ
Лилиана ГРОППА
Виталие КУШНИР
Original Assignee
Валериу КУШНИР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валериу КУШНИР filed Critical Валериу КУШНИР
Priority to MDS20100208A priority Critical patent/MD434Z5/en
Publication of MD434Y publication Critical patent/MD434Y/en
Publication of MD434Z publication Critical patent/MD434Z/en
Publication of MD434Z5 publication Critical patent/MD434Z5/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to medicine, particularly ophthalmology and can be used for predicting the course of endogenous uveitis.According to the invention, the method of predicting the course of endogenous uveitis consists in that on the 3-rd…4-th day of treatment is carried out the blood sampling from which is separated the serum by centrifugation, is determined the total number of T lymphocytes (CD3 +) and the number of adult T lymphocytes (CD5 +), then is calculated the index of activation (IA), according to the formula, in %:and when are determined values of up to 50% is predicted a favorable course of endogenous uveitis, and when are determined values of more than 60% is predicted a unfavorable course.
MDS20100208A 2010-12-01 2010-12-01 Method of predicting the course of endogenous uveitis MD434Z5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100208A MD434Z5 (en) 2010-12-01 2010-12-01 Method of predicting the course of endogenous uveitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100208A MD434Z5 (en) 2010-12-01 2010-12-01 Method of predicting the course of endogenous uveitis

Publications (3)

Publication Number Publication Date
MD434Y MD434Y (en) 2011-11-30
MD434Z MD434Z (en) 2012-06-30
MD434Z5 true MD434Z5 (en) 2012-06-30

Family

ID=45815313

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100208A MD434Z5 (en) 2010-12-01 2010-12-01 Method of predicting the course of endogenous uveitis

Country Status (1)

Country Link
MD (1) MD434Z5 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU764659A1 (en) * 1977-09-29 1980-09-23 2-Ой Московский Ордена Ленина Государственный Медицинский Институт Им. Н.И.Пирогова Method of detecting allergic inflammation at uveitis
SU1727074A1 (en) * 1989-11-14 1992-04-15 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Method for prognosis of uveitis relapses
SU1734022A1 (en) * 1990-01-15 1992-05-15 Астраханский государственный медицинский институт им.А.В.Луначарского Method for assessing effectiveness of treatment for uveitis
SU1783444A1 (en) * 1990-08-16 1992-12-23 Mo Nii Tuberkuleza Method for diagnosis of tuberculous uveitis
RU2157541C1 (en) * 1999-06-01 2000-10-10 Дроздова Елена Александровна Method for predicting uveitis development course in the cases of systemic or syndromic diseases
MD1804G2 (en) * 1999-07-05 2002-06-30 Константин ЖУКОВСКИЙ Method of prognosticating the primary open-angle glaucoma surgical treatment results
MD3073G2 (en) * 2005-07-06 2007-01-31 Наталия ЛУПАШКО Method of prognosticating the risk of appearance of the eyeball degenerative-inflammatory complications after laser discission of the secondary cataract
RU2298188C1 (en) * 2005-09-19 2007-04-27 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Method for predicting unfavorable clinical course of uveitis
MD3795G2 (en) * 2007-08-30 2009-08-31 ЧЕРОЙДА Петру Method for determining the degree of severity of hypertensive retinopathy

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU764659A1 (en) * 1977-09-29 1980-09-23 2-Ой Московский Ордена Ленина Государственный Медицинский Институт Им. Н.И.Пирогова Method of detecting allergic inflammation at uveitis
SU1727074A1 (en) * 1989-11-14 1992-04-15 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Method for prognosis of uveitis relapses
SU1734022A1 (en) * 1990-01-15 1992-05-15 Астраханский государственный медицинский институт им.А.В.Луначарского Method for assessing effectiveness of treatment for uveitis
SU1783444A1 (en) * 1990-08-16 1992-12-23 Mo Nii Tuberkuleza Method for diagnosis of tuberculous uveitis
RU2157541C1 (en) * 1999-06-01 2000-10-10 Дроздова Елена Александровна Method for predicting uveitis development course in the cases of systemic or syndromic diseases
MD1804G2 (en) * 1999-07-05 2002-06-30 Константин ЖУКОВСКИЙ Method of prognosticating the primary open-angle glaucoma surgical treatment results
MD3073G2 (en) * 2005-07-06 2007-01-31 Наталия ЛУПАШКО Method of prognosticating the risk of appearance of the eyeball degenerative-inflammatory complications after laser discission of the secondary cataract
RU2298188C1 (en) * 2005-09-19 2007-04-27 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Method for predicting unfavorable clinical course of uveitis
MD3795G2 (en) * 2007-08-30 2009-08-31 ЧЕРОЙДА Петру Method for determining the degree of severity of hypertensive retinopathy

Also Published As

Publication number Publication date
MD434Y (en) 2011-11-30
MD434Z (en) 2012-06-30

Similar Documents

Publication Publication Date Title
AU2018253580A1 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
WO2012081898A3 (en) Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis
WO2012019103A8 (en) System and apparatus for cell treatment
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
MA34248B1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE
BR112015008179A2 (en) aluminum alloy and vehicle part
MX2015000863A (en) Anti-siglec-15 antibodies.
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
WO2012142300A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event
MA35125B1 (en) Alpha acid glucosidase modified with accelerated treatment
MX359962B (en) Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery.
IN2014DN10132A (en)
WO2012170071A8 (en) Mcam antagonists and methods of treatment
FR2943249B1 (en) USE OF DECORINE TO INCREASE MUSCLE MASS
MX2015008436A (en) Compositions for permeabilising fixed blood cells and uses thereof.
IN2015DN01192A (en)
WO2013170057A3 (en) Quantification of lipoproteins
BR112015014606A2 (en) Reduced iron production method and production device
MX2014001931A (en) Method and kit for depilation.
EA201390964A1 (en) SOLID COMPONENT OF CATALYST, CATALYST INCLUDING NAMED SOLID COMPONENT, AND METHOD (CO) POLYMERIZATION OF α-OLEFINS
MD434Z5 (en) Method of predicting the course of endogenous uveitis
MA20150026A1 (en) Placental stem cells, methods of isolating these cells and use of these methods
MX362870B (en) Composition for use as an abnormal coagulation control plasma in in vitro assays.
WO2010115741A3 (en) New therapeutic approaches for treating neuroinflammatory conditions
EP2593548A4 (en) Human papillomavirus e7 antigen compositions and uses thereof

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees
ND4Y Validity of short term patent extended [from 6 to 10 years]

Expiry date: 20201201

KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees